Trial intelligence / Profile preview

One-year growth study of Avamys versus placebo in pre-pubescent children with perennial allergic rhinitis

2007-005148-26Phase 3Completed

Sponsor
GSK
Start
Feb 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in perennial rhinitis comparing Avamys with Placebo nasal spray (2 arms). Primary endpoint: Difference in mean growth velocity. Started Feb 2008; status: completed.

02

Drugs

fluticasone
03

Conditions

perennial rhinitis

Beyond the preview

Go deeper on 2007-005148-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005148-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call